在HIV阴性儿童中对结核病治疗的矛盾反应:系统性审查和元分析
Nabaneeta Dash1, Lovely Jain2, Meenakshi Malik2
1Department of Telemedicine, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
The American journal of tropical medicine and hygiene
|September 18, 2024
概括
悖论性反应 (PR) 影响了几乎每12名接受结核治疗的未感染艾滋病毒的儿童中有1名. 需要进一步的研究,以了解这种情况的风险因素和最佳管理.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 临床研究 临床研究
背景情况:
- 在结核病 (TB) 治疗期间,矛盾反应 (PR) 是一个担忧,特别是在艾滋病毒共感染的个体中.
- 艾滋病毒阴性儿童中PR的患病率和特征尚不清楚.
- 了解这一群体中的PR对于优化结核病治疗结果至关重要.
研究的目的:
- 系统地审查和估计艾滋病毒阴性儿童矛盾反应 (PR) 的负担和临床特征.
- 为了确定潜在的风险因素,管理策略和与PR相关的结果在这个人口群体中.
- 突出知识差距和进一步研究的需要.
主要方法:
- 通过使用多个数据库 (PubMed,Embase,Web of Science等) 进行了系统审查. ) 的情况.
- 包含的研究是观察性的,包括至少有5例HIV阴性儿童 (<18岁) 的PR病例的病例系列.
- 关于患病率,临床特征,风险因素,管理和结果的数据被提取并使用随机效应元分析汇总.
主要成果:
- 包括10项描述133名艾滋病毒阴性儿童的研究.
- 聚合PR的流行率估计为8.8% (95%CI:2.9%,14.6%).
- 有限的数据表明年龄较小,神经或淋巴结结核结核在患有PR的儿童中更常见;由于异质性,风险因素无法确定.
结论:
- 矛盾反应影响约8.8%的HIV阴性儿童接受结核病治疗.
- 目前的数据不足以确定特定的风险因素或最佳管理策略.
- 需要加强监测和专门研究,以更好地描述HIV阴性儿科人口中的PR.
更多相关视频
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.8K
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
相关概念视频
Pulmonary Tuberculosis I
224
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
224
Pulmonary Tuberculosis V
172
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
172
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Retrovirus Life Cycles
45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
Pulmonary Tuberculosis II
213
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
213
Pulmonary Tuberculosis III
312
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
312
